Piascik MT[au] - Search Results

Year	Number of Results
1976	1
1978	2
1979	2
1980	3
1981	1
1983	2
1984	1
1985	5
1986	3
1987	1
1988	1
1989	3
1990	4
1991	3
1992	1
1993	1
1994	2
1995	1
1996	4
1997	1
1998	1
1999	2
2000	1
2001	2
2002	2
2003	3
2005	1
2006	1
2008	2
2013	1
2017	1
2022	0

1

Hypertension update, JNC8 and beyond.

Shrout T, Rudy DW, Piascik MT. Shrout T, et al. Among authors: piascik mt. Curr Opin Pharmacol. 2017 Apr;33:41-46. doi: 10.1016/j.coph.2017.03.004. Epub 2017 May 16. Curr Opin Pharmacol. 2017. PMID: 28525818 Review.

2

Alpha1-adrenergic receptors: new insights and directions.

Piascik MT, Perez DM. Piascik MT, et al. J Pharmacol Exp Ther. 2001 Aug;298(2):403-10. J Pharmacol Exp Ther. 2001. PMID: 11454900 Review.

3

alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling.

Graham RM, Perez DM, Hwa J, Piascik MT. Graham RM, et al. Among authors: piascik mt. Circ Res. 1996 May;78(5):737-49. doi: 10.1161/01.res.78.5.737. Circ Res. 1996. PMID: 8620593 Review. No abstract available.

4

Aspects of the clinical pharmacology of verapamil, a calcium-entry antagonist.

McAllister RG Jr, Hamann SR, Piascik MT. McAllister RG Jr, et al. Among authors: piascik mt. Biopharm Drug Dispos. 1983 Jul-Sep;4(3):203-11. doi: 10.1002/bdd.2510040302. Biopharm Drug Dispos. 1983. PMID: 6354294 Review. No abstract available.

5

Recent advances in the molecular pharmacology of the alpha 1-adrenergic receptors.

Guarino RD, Perez DM, Piascik MT. Guarino RD, et al. Among authors: piascik mt. Cell Signal. 1996 Aug;8(5):323-33. doi: 10.1016/0898-6568(96)00066-6. Cell Signal. 1996. PMID: 8911680 Review.

6

Aspects of the clinical pharmacology of nifedipine, a dihydropyridine calcium-entry antagonist.

Hamann SR, Piascik MT, McAllister RG Jr. Hamann SR, et al. Among authors: piascik mt. Biopharm Drug Dispos. 1986 Jan-Feb;7(1):1-10. doi: 10.1002/bdd.2510070102. Biopharm Drug Dispos. 1986. PMID: 3513860 Review.

7

Alpha-adrenoceptors and vascular regulation: molecular, pharmacologic and clinical correlates.

Piascik MT, Soltis EE, Piascik MM, Macmillan LB. Piascik MT, et al. Pharmacol Ther. 1996;72(3):215-41. doi: 10.1016/s0163-7258(96)00117-9. Pharmacol Ther. 1996. PMID: 9364576 Review.

8

α₁A-adrenergic receptors regulate cardiac hypertrophy in vivo through interleukin-6 secretion.

Papay RS, Shi T, Piascik MT, Naga Prasad SV, Perez DM. Papay RS, et al. Among authors: piascik mt. Mol Pharmacol. 2013 May;83(5):939-48. doi: 10.1124/mol.112.084483. Epub 2013 Feb 12. Mol Pharmacol. 2013. PMID: 23404509 Free PMC article.

9

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

MacMillan LB, Hein L, Smith MS, Piascik MT, Limbird LE. MacMillan LB, et al. Among authors: piascik mt. Science. 1996 Aug 9;273(5276):801-3. doi: 10.1126/science.273.5276.801. Science. 1996. PMID: 8670421

10

The alpha1D-adrenergic receptor induces vascular smooth muscle apoptosis via a p53-dependent mechanism.

García-Cazarín ML, Smith JL, Clair DK, Piascik MT. García-Cazarín ML, et al. Among authors: piascik mt. Mol Pharmacol. 2008 Oct;74(4):1000-7. doi: 10.1124/mol.108.047993. Epub 2008 Jul 15. Mol Pharmacol. 2008. PMID: 18628404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results